Hashimoto encephalopathy - Steroid-responsive encephalopathy associated with autoimmune thyroiditis: A neuropsychiatry challenge;Hashimoto-enzephalopathie - Steroid-sensitive enzephalopathie: Eine neuropsychiatrische herausforderung

Nervenheilkunde

Volumn 26, Issue 5, 2007, Pages 357-361

  Unger, J ^a,b   Bergemann, N ^a   Schwaninger, M ^b  

^a Sektion Phänomenologische Psychopathologie und Psychotherapie   (Germany)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Hashimoto's encephalopathy; Neuropsychiatric syndrome; Steroid responsive encephalopathy associated with autoimmune thyroiditis (SREAT); Steroid responsive encephalopathy associated with Hashimoto's thyroiditis (SREHT)

Indexed keywords

AZATHIOPRINE; CARBIMAZOLE; CYCLOPHOSPHAMIDE; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN; LEVOTHYROXINE; MEPREDNISONE; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; STEROID;

ALGORITHM; ARTICLE; AUTOIMMUNE THYROIDITIS; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE COURSE; DRUG RESPONSE; HASHIMOTO ENCEPHALOPATHY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; NEUROPSYCHIATRY; PATHOGENESIS; STEROID THERAPY; SYMPTOM;

EID: 34347357719     PISSN: 07221541     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1626870     Document Type: Article

References (39)

1. Brain L, Jellinek EH, Ball K. Hashimoto's disease and encephalopathy. Lancet 1966; 2: 512-514.
2. Chong JY, Rowland LP, Utiger RD. Hashimoto encephalopathy: syndrom or myth? Arch Neurol 2003; 60: 164-171.
3. Hartmann M, Schaner B, Scheglmann K, Bücking A, Pfister R. Hashimoto-Enzephalopathie. Steroid-sensitive Enzephalopathie bei Hashimoto-Thyreoiditis. Nervenarzt 2000; 71: 489-494.
4. Taylor SE, Garalda ME, Tudor-Williams G, Martinez-Alier N. An organic cause of neuropsychiatric illness in adolescence. Lancet 2003; 361: 572.
5. Mahmud FH, Lteif AN, Renaud DL, Reed AM, Brands CK. Steroid-responsive encephalopathy associated with Hashimoto's thyroiditis in an adolescent with chronic hallucinations and depression: case report and review. Pediatrics Sep 2003; 112: 686-690.
6. v. Maydell B, Kopp M, v. Komorowski G, Joe A, Juengling FD, Korinthenberg R. Hashimoto encephalopathy - is it underdiagnosed in pediatric patients? Neuropediatrics 2002; 33: 86-89.
7. Watemberg N, Willis D, Pellock JM. Encephalopathy as the presenting symptom of Hashimoto's thyroiditis. J Child Neurol 2000; 15: 66-69.
8. Castillo P, Woodruff B, Caselli R et al. Steriod-responsive encephalopathy associated with autoimmune thyroidits. Arch Neurol 2006, 63: 197-202.
9. Kothbauer-Margreiter I, Sturzenegger M, Komor J, Baumgartner R, Hess CW. Encephalopathy associated with Hashimoto thyroiditis: diagnosis and treatment. J Neurol 1996; 243: 585-593.
10. Peschen-Rosin R, Schabet M, Dichgans J. Manifestion of Hashimoto's encephalopathy years before onset of thyroid disease. Eur Neurol 1999; 41: 79-84.
11. Canton A, de Fabregas O, Tintore M, Mesa J, Codina A, Simo R. Encephalopathy associated to autoimmune thyroid disease: more appropriate term for an underestimated condition? J Neurol Sci 2000; 176: 65-69.
12. Marshall GA, Doyle JJ. Long-Term Treatment of Hashimoto's Encephalopathy. J Neuropsychiatry Clin Neurosci 2006; 18 (1): 14-20.
13. Shaw PJ WT, Newman PK, Cleland PG, Cartlidge NEF. Hashimoto's encephalopathy: a steroid-responsive disorder associated with high anti-thyroid antibody titers - report of 5 cases. Neurology 1991; 41: 228-233.
14. Forchetti CM, Katsamakis G, Garron DC. Autoimmune thyroiditis and a rapidly progressive dementia: Global hypoperfusion on SPECT scanning suggests a possible mechanism. Neurology 1997; 49: 623-626.
15. Latinville D, Bernardi O, Cougoule JP et al. Thyriodite d'Hashimoto et encephalopatie myoclonique: hypothesese pathogeniques. Rev Neurol 1985; 141: 55-58.
16. Nolte KW, Unbehaun A, Sieker H, KlossTM, Paulus W. Hashimoto encephalopathy: a brainstem vasculitis? Neurology 2000; 54: 769-770.
17. Duffey P, Yee S, Reid IN et al. Hashimoto's encephalopathy: a brainstem vasculitis? Neurol 2000; 54: 769-770.
18. Shibata N, Yamamoto Y, Sunami N, Suga M, Yamashita Y. Isolated angiitis of the CNS associated with Hashimoto's disease. Rinsho Shinkeigaku 1992; 32: 191-198.
19. Chaudhuri A, Behan PO. The clinical spectrum, diagnosis, pathogenesis and treatment of hashimoto's encephalopathy (recurrent acute disseminated encephalomyelitis). Curr Med Chem 2003; 10: 1945-1953.
20. Ishii K, Hayashi A, Tamaoka A et al. Thyrotropin-releasing hormone-induced myoclonus and tremor in a patient with Hashimoto's encephalopathy. Am J Med Sci 1995; 310: 202-205.
21. Oide T, Tokuda T, Yazaki M et al. Anti-neuronal autoantibody in Hashimoto's encephalopathy. Neuropathological, immunhistochemical, and biochemical analysis of two patients. J Neurol Sci 2004; 217: 7-12.
22. Shein M, Apter A, Dickerman Z, Tyano S, Gadoth N. Encephalopathy in compensated Hashimoto thyroiditis: a clinical expression of autoimmune cerebral vasculitis. Brain Dev 1986; 8: 60-64.
23. Laske C, Leyhe T, Buchkremer G, Wormstall H. Depression bei Hashimoto- Enzephalopathie. Erfolgreiche Behandlung einer schweren depressiven Episode mit einem Kortikosteroid als Add-on Therapie. Nervenarzt 2005; 76: 617-622.
24. Rolland F, Chevrollier JP. Depression, anti-thyroid antibodies and Hashimoto encephalopathy. Encephale 2001; 27: 137-142.
25. Archambeaud F, Galinat S, Regouby Y et al. Hashimoto encephalopathy. Analysis of four case reports. Rev Med Interne 2001; 22: 653-659.
26. Seipelt M, Zerr I, Nau R et al. Hashimoto's encephalitis as a differential diagnosis of Creutzfeld-Jakob disease. J Neurol Neurosurg Psychiatry 1999; 66: 172-176.
27. Thorlacius S, Aarli JA, Riise T, Matre R, Johnsen HJ. Associated disorders in myastenia gravis: autoimmune diseases and their relation to thymectomy. Acta Neurol Scand 1989; 80: 290-295.
28. Ferracci F, Moretto G, Candeago RM et al. Anti-thyroid antibodies in the CSF. Their role in the pathogenesis of Hashimoto's encephalopathy. Neurology 2003; 60: 712-714.
29. Ferracci F, Bertiato G, Moretto G. Hashimoto's encephalopathy: epidemiologic data and pathogenetic considerations. J Neurol Sci 2004; 217: 165-168.
30. Henchey R, Cibula J, Helveston W, Malone J, Gilmore RL. Encephalographic findings in Hashimoto's encephalopathy. Neurology 1995; 45: 977-981.
31. Schauble B, Castillo PR, Boeve BF, Westmoreland BF. EEG findings in steroid-responsive encephalopathy associated with autoimmune thyroiditis. Clin Neurophysiol 2003; 114: 32-37.
32. Bohnen NI, Parnell KJ, Harper CM. Reversible MRI findings in a patient with Hashimoto's encephalopathy. Neurology 1997; 49: 246-247.
33. Zettinig G, Asenbaum S, Fueger BJ et al. Increased prevalence of sublinical brain perfusion abnormalities in patients with autoimmune thyroiditis: evidence of Hashimoto's encephalitis? Clin Endocrinol 2003; 59: 637-643.
34. Becker H, Hofmann M, von Einsiedel H, Conrad B, Sander D. Umschriebene Vaskulitis mit Posteriorinfarkt bei Hashimoto-Enzephalopathie. Nervenarzt 2002; 73: 376-379.
35. Flynn SD, Nishiyama RH, Bigos ST. Autoimmune thyroid disease: immunological, pathological and clinical aspects. Crit Rev Clin Lab Sci 1988; 26: 43-94.
36. Vasconcellos E, Pina-Garza JE, Fakhoury T et al. Pediatric manifestations of hashimoto's encephalopathy. Pediatr Neurol 1999; 20: 394-398.
37. Galluzi S, Geroldi C, Zanetti O et al. Hashimoto's encephalopathy in the elderly: relationship to cognitive impairment. J Geriatr Psychiatry Neurol 2002; 15: 175-179.
38. Dayan CM, Daniels GH. Chronic autoimmune thyroidits. N Engl J Med 1996; 335: 99-107.
39. Hussain NS, Rumbaugh J, Kerr D, Nath A, Hillis AE. Effects of prednisone and plasma exchange on cognitive impairment in Hashimoto encephalopathy. Neurology 2005; 64: 165-166.